Benquinox
CAS: 495-73-8
Rif. 3D-AAA49573
1g | 1.855,00 € | ||
2g | 2.783,00 € | ||
5g | 5.796,00 € | ||
250mg | 832,00 € | ||
500mg | 1.218,00 € |
Informazioni sul prodotto
- 1,4-Benzoquinone 1-benzoylhydrazone 4-oxime
- 1,4-Benzoquinone N′-benzoylhydrazone oxime
- Bayer 15080
- Benzoic acid, (4-oxo-2,5-cyclohexadien-1-ylidene)hydrazide 4-oxime
- Benzoic acid, (4-oxo-2,5-cyclohexadien-1-ylidene)hydrazide, oxime
- Benzoic acid, 2-[4-(hydroxyimino)-2,5-cyclohexadien-1-ylidene]hydrazide
- Benzoic acid, [4-(hydroxyimino)-2,5-cyclohexadien-1-ylidene]hydrazide
- Ceredon
- Ceredon T
- Cerenox
- Vedi altri sinonimi
- Lerenox
- N'-(4-nitrosophenyl)benzohydrazide
- N'-[(1E,4E)-4-(hydroxyimino)cyclohexa-2,5-dien-1-ylidene]benzohydrazide
- P-Benzoquinone 1-Benzoylhydrazon-4-Oxime
- Quinone oxime benzoylhydrazone
- p-Benzoquinone oxime benzoylhydrazone
Benquinox is a potent inhibitor of protein kinases that has shown promise in the treatment of cancer. It works by blocking the activity of certain kinases that are involved in cell growth and division, leading to apoptosis (programmed cell death) in cancer cells. Benquinox is an analog of donepezil, a drug used to treat Alzheimer's disease. Studies have shown that Benquinox inhibits tumor growth and induces apoptosis in human cancer cell lines. It has also been found to be effective against urinary tract tumors in Chinese patients. As an anticancer agent, Benquinox is being investigated for its potential use as a targeted therapy for various types of cancer. Its ability to inhibit kinases makes it a promising candidate for combination therapies with other kinase inhibitors.
Proprietà chimiche
Richiesta tecnica su: 3D-AAA49573 Benquinox
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.